Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Apple makes non-invasive glucose monitoring breakthrough - Bloomberg

Published 02/23/2023, 02:56 AM
Updated 02/23/2023, 02:56 AM
© Reuters.

© Reuters.

By Sam Boughedda

Apple (NASDAQ:AAPL) believes it could eventually bring a non-invasive and continuous blood glucose monitoring product to market after hitting major milestones, Bloomberg reported Wednesday.

The secret project, labeled E5, aims to measure how much glucose is in someone's body without pricking the skin for blood.

The current methods, widely used by type 1 diabetics, involve either using a blood glucose monitor that pokes the skin for a small blood sample or a sensor attached to the arm with a filament under the skin that measures the glucose levels in the body's interstitial fluid. The sensors are replaced every two weeks.

Companies such as DexCom Inc (NASDAQ:DXCM), Insulet (NASDAQ:PODD), Tandem Diabetes Care Inc (NASDAQ:TNDM), and Abbott Laboratories (NYSE:ABT) make these devices. Their share prices were impacted on Wednesday due to the Bloomberg report.

If perfected, the Apple product could be a boon to diabetics and establish Apple as a powerhouse in health care. In addition, if the device were added to the Apple Watch, it would make it a must-have item for many of the millions of diabetics around the world.

Bloomberg said its sources warned there are still years of work ahead. Its potential device is said to use a chip technology known as silicon photonics and a measurement process called optical absorption spectroscopy that uses lasers to cast specific wavelengths of light into an area just below the skin where there is interstitial fluid.

There are said to be hundreds of engineers working on the project as part of Apple's Exploratory Design Group, or XDG.

Apple's system is now considered at a proof-of-concept stage, Bloomberg said people familiar with the effort told them. However, while the tech giant believes the technology is viable, it needs to be decreased to a more practical size.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.